illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Xbrane Biopharma
Company logo

Xbrane Biopharma | Sustainability Performance

https://www.xbrane.com
Linkedin

Xbrane Biopharma AB focuses on the development of biologic drugs, particularly in the area of biosimilars. The company aims to address unmet medical needs through its research and development initiatives in pharmaceuticals.

2008

Sweden

51 - 200 employees

Biotechnology

$10M - 25M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#2340
Overall
#164
in Sweden
#37
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Environmental
Carbon certificatesDigital emissions
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Moberg Pharma

Sweden, Hospital & Health Care, Pharmaceuticals


Company logo
Recipharm

Sweden, Hospital & Health Care, Pharmaceuticals


Company logo
RaySafe

Sweden, Hospital & Health Care, Medical Device

Market cap

2.2B $, 2026▼219.8% YoY

Revenue

15.5M $, 2025▼30.3% YoY

R&D intensity

76.97% 2025

Digital Emissions


CO2e per visit (g)

Industry benchmark

B/M 0.26 g
0.78 g

C
Environmental ScoreScore C
Green HostingYes
Download Digital Emissions AnalysisPowered by illuminem and Dedalo AI

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Xbrane Biopharma reported sustained losses during biosimilar development with material going-concern uncertainty.
Powered by illuminem

Carbon certificate projects

Reveal data for 3 credits

Sector:
SubsectorCountryTransaction date
ⓘ
20192020202120222023Total
**************----**************

Powered by AlliedOffsets and illuminem

Market cap

2.2B $, 2026▼219.8% YoY

Revenue

15.5M $, FY2025▼30.3% YoY

EBITDA

-7.3M $, FY2025▼9.1% YoY

Operating margin

-47% Industry: -370▼131.6% YoY

Revenue & EBITDA

$15.5MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-39.8M 2025▲52.4% YoY

Capex

14.2M 2025▲62.6% YoY

Debt/equity ratio

0.1 Industry: 2▼NaN% YoY

R&D intensity

77.0%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

21.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.0

▼ 0.3%

2023

0.0

▼ 39.1%

2024

0.0

▲ 13.6%

2025

0.4

2029

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

45%
Independent Directors

5 out of 11 incl. management

Powered by illuminem

Overall score

58

Environment

50

Social

45

Governance

79

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees


Total sustainability employees

2-3



    Available in
    Scale package

    Access
  • Email

  • Email